与GABABR抗体相对比的帕拉内oplastic和非帕拉内oplastic自身免疫脑炎的比较研究
Florian Lamblin1, Jeroen Kerstens1, Sergio Muñiz-Castrillo1
1From the French Reference Center on Paraneoplastic Neurological Syndrome and Autoimmune Encephalitis (F.L., V.R., G.P., M.V., A.-L.P., M.B., B.J., J.H.), Hospices Civils de Lyon; Institut MeLiS INSERM U1314/CNRS UMR 5284 (F.L., V.R., G.P., M.V., A.-L.P., M.B., B.J., J.H.), Université Claude Bernard Lyon 1; Department of Neurology (F.L.), University Hospital of La Réunion, Saint-Pierre (La Réunion), France; Department of Neurology (J.K., M.H.V.C.-H., M.A.D.B., J.M.V., M.J.T.), Erasmus Medical Center, Rotterdam, The Netherlands; Stanford Center for Sleep Sciences and Medicine (S.M.-C., V.P.S., E.M.), Stanford University, Palo Alto, CA; Clinical Neurology (A.V.), Department of Neurosciences, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DAME) (A.V.), University of Udine Medical School, Italy; Department of Immunology (D.G.), Hôpital Lyon Sud, Hospices Civils de Lyon, France; Department of Immunology (M.S.), Laboratory Medical Immunology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Neurology (L.T., L.H.), University Hospital of Nancy; Department of Clinical Neurosciences (J.A., C.M.), University Hospital of Bordeaux, Bordeaux, France; Department of Neuro-Oncology (D.P.), Pitié Salpêtrière Hospital, AP-HP, Paris; Department of Neurology (L.K.), University Hospital of Strasbourg; Department of Neurology (V.B.), Côte d'Azur University, Nice; Department of Neurology (J.-C.G.A.), University Hospital of Saint-Etienne; Stroke Center Neurology Division (A.W.), Hopital Foch, Suresnes; University Grenoble Alpes (P.K.), Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences; Neurological Intensive Care Unit (S.D.), Pitié-Salpêtrière Hospital, AP-HP, Paris; Department of Neurology (G.A.), Hôpitaux Civils de Colmar; Department of Public Health (N.T., M.N.), Hospices Civils de Lyon; and Department of Medicine (A.M.), Centre Leon Berard, UNICANCER, Lyon, France.
带有胺黄油酸B受体抗体 (GABABR-AE) 的非原性自身免疫脑炎影响较年轻的患者,结果更好. 这表明这些病例的治疗策略可能比瘤类型更为密集.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经免疫学 神经免疫学
背景情况:
- 与胺黄油酸B受体抗体 (GABABR-AE) 相关的副发性自身免疫脑炎 (AE) 通常表现为功能不良的结果和高死亡率.
- 非瘤性GABABR-AE的临床特征和预后研究较少.
- 了解神经瘤和非神经瘤形式之间的差异对于优化患者管理至关重要.
研究的目的:
- 为了比较GABABR-AE.R-AE.R-AE.RGABABR-AE.R-AE.R-AE.RGABABR-AE.R-AE.R-AE.R-AE.RGABABR-AE.R-AE.R-AE.R-AE.
- 确定这两种疾病形式之间的人口,临床和免疫学差异.
- 评估影响GABABR-AE.患者预后的因素.
主要方法:
- 法国和荷兰参考中心对被诊断患有GABABR-AE的患者进行了回顾性分析.
- 脑神经学结果,人口统计数据和临床表现的比较,介于副瘤和非副瘤组.
- 在现有样本上进行了免疫球蛋白G (IgG) 异型鉴定和人类白细胞抗原 (HLA) 基因鉴定.
主要成果:
- 非瘤性GABABR-AE患者显著年轻,并且呈现出不同的人口分布.
- 非神经瘤病例显示中枢神经液细胞形成的频率更高,很少与KCTD16-abs.相关.
- 与非神经瘤病例相比,非神经瘤的GABABR-AE患者经历了明显更好的神经学结果 (有利的mRS ≤2) 和生存率.
结论:
- 非瘤性GABABR-AE的特点是患者年龄较小,没有KCTD16-abs,以及更好的神经和生命预后.
- 在非神经瘤病例中,改善的结果可能与更积极或更密集的治疗策略有关.
- 需要进一步研究表皮性和非表皮性GABABR-AE背后的独特免疫机制.
更多相关视频
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
